Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
J Biol Chem ; 275(19): 14440-5, 2000 May 12.
Article in English | MEDLINE | ID: mdl-10748169

ABSTRACT

Perturbed Ca(2+) homeostasis is a common molecular consequence of familial Alzheimer's disease-linked presenilin mutations. We report here the molecular interaction of the large hydrophilic loop region of presenilin 2 (PS2) with sorcin, a penta-EF-hand Ca(2+)-binding protein that serves as a modulator of the ryanodine receptor intracellular Ca(2+) channel. The association of endogenous sorcin and PS2 was demonstrated in cultured cells and human brain tissues. Membrane-associated sorcin and a subset of the functional PS2 complexes were co-localized to a novel subcellular fraction that is distinctively positive for calcineurin B. Sorcin was found to interact with PS2 endoproteolytic fragments but not full-length PS2, and the sorcin/PS2 interaction was greatly enhanced by treatment with the Ca(2+) ionophore A23187. Our findings reveal a molecular link between PS2 and intracellular Ca(2+) channels (i.e. ryanodine receptor) and substantiate normal and/or pathological roles of PS2 in intracellular Ca(2+) homeostasis.


Subject(s)
Calcium-Binding Proteins/metabolism , Membrane Proteins/metabolism , Ryanodine Receptor Calcium Release Channel/metabolism , Amino Acid Sequence , Biological Transport , Calcium/metabolism , Cell Line , Cell Membrane/metabolism , Humans , Hydrolysis , Membrane Proteins/chemistry , Molecular Sequence Data , Presenilin-2 , Sequence Homology, Amino Acid , Subcellular Fractions/metabolism
2.
Ann Neurol ; 41(6): 809-13, 1997 Jun.
Article in English | MEDLINE | ID: mdl-9189043

ABSTRACT

The prevalence of known mutations in presenilin genes (PS1 and PS2) causing early-onset familial Alzheimer's disease (FAD) was assessed in a population of 98 singleton early-onset AD cases, 29 early-onset FAD cases, and 15 late-onset FAD cases. None of the cases tested positive for the eight mutations initially reported, and none of these mutations were observed in 60 age-matched controls. A novel mutation (R269H) in PS1 was found in a single case of early-onset AD but not in any other AD or control case. Thus, the PS mutations tested are quite rare in early-onset AD. Amyloid beta protein (A beta) deposition was investigated in the temporal cortex of the R269H mutation case using end-specific monoclonal antibodies to detect the presence of A beta x-40 and A beta x-42 subspecies. Stereologically unbiased tangle and neuropil thread counts were obtained from the same region. R269H PS1 mutation was associated with early age of dementia onset, higher amounts of total A beta and A beta x-42, and increased neuronal cytoskeletal changes. Thus, if the changes observed on this case prove to be typical of PS1 mutations, PS1 mutations may impact both amyloid deposition and neurofibrillary pathology.


Subject(s)
Alzheimer Disease/genetics , Alzheimer Disease/metabolism , Amyloid beta-Peptides/metabolism , Membrane Proteins/genetics , Mutation , Neurofibrils/pathology , Age of Onset , Aged , Alzheimer Disease/pathology , Brain/metabolism , Brain/pathology , Female , Humans , Male , Middle Aged , Presenilin-1
SELECTION OF CITATIONS
SEARCH DETAIL
...